March 22 (Reuters) - Teva Pharmaceutical Industries (NYSE:TEVA) Ltd:
* ACT METHYLPHENIDATE ER® TABLETS, A GENERIC VERSION OF C CONCERTA® FOR THE TREATMENT OF ADHD
* TEVA CANADA LIMITED SAYS HEALTH CANADA APPROVED ITS APPLICATION FOR (C)ACT METHYLPHENIDATE ER TABLETS